{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2014"],"condition":["Colorectal Cancer"],"disease":["Colorectal Cancer"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2630698"],"location":["Japan"],"study_start_month":["9"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"TANDEM-IRI-TACE combined with systemic FOLFIRI for colorectal liver metastases after oxaliplatin regimen failure: Phase I dose escalation study","description":"Interventions: TACE will be conducted every 5 weeks. Systemic FOLFIRI will be conducted every 2 weeks.\nPrimary outcome(s): Dose Limiting Toxicity,Recommended Dose\nStudy Design: Single arm Non-randomized","dates":{"creation":"2014-09-15"},"accession":"2630698","cross_references":{"Japan Primary Registries Network":["JPRN-UMIN000015367"]}}